Liquidia
LQDA
54.43
-2.20
-3.88%
Liquidia
US · LQDA
#2623 by market cap
Listed 2018
54.43
-2.20
-3.88%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
D-
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Deteriorating
2 4
■ Upgrades■ Downgrades
- 2 upgrades vs 4 downgrades among tracked analyst rating changes.
- The single most recent change was actually an upgrade (LifeSci Capital moved from Hold to Buy on 2026-10-14), though the broader window skews toward downgrades.
Analyst consensus 8 analysts
Buy
Avg price target 63.25 +16.2%
Price target rangecurrent 54.43
Low33.00
Avg63.25
High87.00
Buy 75%
Hold 25%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-13 | H.C. Wainwright | -- | Buy | 76.00 |
| 2026-11-11 | Raymond James | -- | Buy | 77.00 |
| 2026-11-11 | BofA Securities | -- | Hold | 54.00 |
| 2026-11-10 | BTIG | -- | Buy | 87.00 |
| 2026-11-10 | BofA Securities | -- | Hold | 54.00 |
| 2026-11-10 | Jefferies | -- | Buy | 62.00 |
| 2026-10-15 | H.C. Wainwright | -- | Buy | 65.00 |
| 2026-10-14 | Wells Fargo | -- | Hold | 33.00 |
| 2026-10-14 | LifeSci Capital | -- | Buy | 59.00 |
| 2026-10-14 | BTIG | -- | Buy | 70.00 |
| 2026-10-14 | BofA Securities | -- | Hold | 42.00 |
| 2026-10-14 | Needham | -- | Buy | 58.00 |
| 2026-10-13 | Wells Fargo | -- | Hold | 33.00 |
| 2026-10-09 | BofA Securities | -- | Hold | 38.00 |
| 2026-10-05 | Jefferies | -- | Buy | 45.00 |
| 2026-10-02 | H.C. Wainwright | -- | Buy | 58.00 |
| 2026-10-01 | Raymond James | -- | Buy | 53.00 |
| 2026-10-01 | BTIG | -- | Hold | -- |
| 2026-10-01 | BofA Securities | -- | Hold | -- |
| 2026-10-01 | Jefferies | -- | Buy | 45.00 |
| 2026-09-30 | LifeSci Capital | -- | Hold | -- |
| 2026-09-30 | Raymond James | -- | Buy | -- |
| 2026-09-30 | Needham | -- | Buy | 72.00 |
| 2026-09-08 | Wells Fargo | -- | Buy | 108.00 |
| 2026-09-02 | Wells Fargo | -- | Buy | 108.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-10-14 | LifeSci Capital | Hold → Buy | 59.00 |
| 2026-10-14 | BTIG | Hold → Buy | 70.00 |
| 2026-10-13 | Wells Fargo | Buy → Hold | 33.00 |
| 2026-10-01 | BTIG | Buy → Hold | -- |
| 2026-08-12 | LifeSci Capital | Buy → Hold | 90.00 |
| 2026-06-29 | BofA Securities | Buy → Hold | 79.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-10 | -- | ±9.99% | +7.37% (in line) |
| 2026/Q2 | 2026-08-12 | -- | ±13.01% | -10.52% (in line) |
| 2026/Q1 | 2026-05-11 | -- | ±13.24% | +25.60% (beat) |
| 2025/Q4 | 2026-03-05 | -- | ±16.84% | +0.41% (in line) |
| 2025/Q3 | 2025-11-03 | -- | ±31.89% | +3.53% (in line) |
| 2025/Q2 | 2025-08-12 | -- | ±18.47% | +13.68% (in line) |
| 2025/Q1 | 2025-05-08 | -- | ±16.55% | -1.16% (in line) |
| 2024/Q4 | 2025-03-19 | After close | ±7.07% | +3.49% (in line) |
| 2024/Q3 | 2024-11-13 | -- | ±9.22% | -3.39% (in line) |
| 2024/Q2 | 2024-08-07 | -- | ±18.63% | -3.44% (in line) |
| 2024/Q1 | 2024-05-14 | -- | ±24.70% | -1.48% (in line) |
| 2023/Q4 | 2024-03-13 | -- | ±14.70% | +5.36% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:33 · For reference only, not investment advice and not tailored to your situation.
Liquidia discussion 0 comments